A root canal can be challenging under the best of circumstances, for the patient and the dentist.
While the patient may be happily oblivious to the experience thanks to the miracle of modern-day anesthetics, the endodontist faces twin challenges while rooting around in your mouth: thoroughly and quickly cleaning and disinfecting the area being treated, and promoting rapid healing.
A new journal article by a senior licensing associate in the University of Iowa Research Foundation (UIRF) argues that academic tech transfer activities contribute enormously to society and the economy, and that diminishing funding of those efforts jeopardize U.S. dominance in research-based discovery and innovation.
In 2001, University of Iowa Professor Jerald Moon wanted to show students in his phonetics class how the sounds of different languages are produced.
Moon knew his students could one day work with people who have speech disorders, so a deep understanding of how the tongue, lips, voice box, and other organs work together to make sounds was important.
Researchers interested in learning about easier and quicker ways to transfer reagents are invited to meet one-on-one with Ximbio Business Development Manager Jon Viola on Friday, April 26.
Ximbio, the world’s largest non-profit dedicated to broadening access to life science research tools, has teamed up with the University of Iowa Research Foundation to make the university’s research tools more readily available to researchers.
The National Academy of Inventors (NAI) has named University of Iowa neurosurgeon and entrepreneur Matthew Howard, M.D., a 2018 fellow.
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy.
University of Iowa researchers may have recently heard about new regulations related to the 1980 Bayh-Dole Act around Intellectual Property (IP) for universities that receive federal grants.
IDx, a privately held AI diagnostics company built on University of Iowa research, announced today that it has filed its De Novo submission to the Food and Drug Administration (FDA) for IDx-DR, an AI-based system for the autonomous detection of diabetic retinopathy — a leading cause of blindness.
University of Iowa spinout company Voxello, which develops technologies that allow hospitalized patients to overcome communication barriers, recently received three grants to help advance its research and development.
